Home / Share Price Target / Hesterbio
Hester Biosciences Share Price Target 2024, 2025, 2026 to 2039 With Charts
Hester Biosciences Limited | |||
 | Symbol: HESTERBIO | ||
| Price: ₹2,456.69 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Hester Biosciences Brief Company Overview
- 1.1: Hester Biosciences Limited: A Leader in Animal Healthcare
- 1.2: Hester Biosciences Financial Performance
- 1.2.1: Is Hester Biosciences A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Hester Biosciences Share Price Target For 2024
- 2.1.1: Hester Biosciences Share Price Target Table For 2024
- 2.1.2: Summary: Hester Biosciences Share Price Prediction For 2024
- 2.2: Hester Biosciences Share Price Target For 2025
- 2.2.1: Hester Biosciences Share Price Target Table For 2025
- 2.2.2: Summary: Hester Biosciences Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Hester Biosciences Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Hester Biosciences Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Hester Biosciences Past Performance
Hester Biosciences Brief Company Overview
Hester Biosciences Limited: A Leader in Animal Healthcare
Established in 1987, Hester Biosciences Limited is a renowned manufacturer and trader of veterinary vaccines and animal health products in India and globally.
The company's diverse product range caters to poultry, livestock, and pet healthcare. Poultry vaccines include those for Newcastle disease, infectious bronchitis, and avian encephalomyelitis, while livestock vaccines protect against goat pox, peste des petits ruminants, and contagious bovine pleuropneumonia.
Beyond vaccines, Hester Biosciences offers a comprehensive suite of animal health products, such as biosecurity solutions, herbal supplements, and feed supplements. Its petcare products include gut health solutions, NSAIDs, and anti-infective formulations.
The company's commitment to innovation is evident in its diagnostic kits for enzyme-linked immunosorbent assay and polymerase chain reaction.
Advertisement
Hester Biosciences Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,274.01 Crore | Market valuation of Hester Biosciences's shares. |
| Revenue (TTM) | 316.4 Crore | Total revenue generated by Hester Biosciences over the past twelve months. |
| Net Income (TTM) | +23.46 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 19.64% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 7.41% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +14.3% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +100.69% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 77.65 | Company's total debt divided by total shareholder equity. |
| Total Debt | 244.02 Crore | Sum of Hester Biosciences's current & long-term financial obligations. |
| Total Cash | 16.78 Crore | Total amount of liquid funds available to Hester Biosciences. |
| Beta | 0.69 | Beta is less than 1 indicating that the Hester Biosciences's price is less volatile than the market. |
Is Hester Biosciences A Good Buy For Long Term?
Hester Biosciences, a small-cap stock with a market capitalization of ₹2,100 crore, presents a mixed picture for long-term investors. While its 5-year return of 117.78% is impressive, and the YTD return sits at 68.50%, the recent 3-month performance shows a -21.17% drop. A substantial debt of ₹244.02 crore (Q2 2024-25) against a meager cash balance of ₹16.78 crore raises concerns. Though revenue growth is positive (14.3% QoQ), the profit margin of 7.41% needs improvement. Considering these factors, it's an average buy for the long term, requiring careful monitoring of debt reduction and profit margin expansion.
To predict the Hester Biosciences's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Hester Biosciences Share Price Target For 2024
The line chart displays the monthly closing prices of Hester Biosciences with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Hester Biosciences shares in 2024, see the table below.
Advertisement
Hester Biosciences Share Price Target Table For 2024
| Hester Biosciences's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 2549.95 (+3.79%) | Price Action: Nov 2021 High |
| 2024 Target 2 | 2516.64 (+2.44%) | Price Action: Sep 2024 High |
| 2024 Target 1 | 2490.00 (+1.35%) | Price Action: 06 Nov 2024 High |
| Current Price | 2456.69 | Hester Biosciences's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 2434.50 (-0.91%) | Price Action: Sep 2024 Low |
| Stop Loss 2 | 2403.89 (-2.15%) | Price Action: Aug 2024 High |
| Stop Loss 3 | 2375.00 (-3.33%) | Price Action: Jun 2022 High |
Summary: Hester Biosciences Share Price Prediction For 2024
In summary, Hester Biosciences has surged by ₹998.79, achieving a notable +68.51% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Hester Biosciences for 2024 predicts an additional rise of 1.35% to 3.79% by the end of 2024 with three potential targets T1: 2490.00, T2: 2516.64, T3: 2549.95. Stop Loss at SL1: 2434.50, SL2: 2403.89, SL3: 2375.00.
Hester Biosciences has a 52-week high of ₹3379.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1292.84, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Hester Biosciences.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Hester Biosciences Share Price Target For 2025
The line chart displays the monthly closing prices of Hester Biosciences with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Hester Biosciences shares in 2025, see the table below.
Advertisement
Hester Biosciences Share Price Target Table For 2025
| Hester Biosciences's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 3761.32 (+53.1%) | Price Action: Chart |
| 2025 Target 2 | 3691.19 (+50.25%) | Custom Fibonacci Extension Lvl 64.9% |
| 2025 Target 1 | 3643.91 (+48.32%) | Fibonacci Extension Level 123.6% |
| Current Price | 2456.69 | Hester Biosciences's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 2165.25 (-11.87%) | Price Action: Feb 2022 Low |
| Stop Loss 2 | 2135.25 (-13.09%) | Price Action: Aug 2021 Low |
| Stop Loss 3 | 2113.65 (-13.97%) | Price Action: May 2021 Low |
Summary: Hester Biosciences Share Price Prediction For 2025
In summary, Hester Biosciences has surged by ₹998.79, achieving a notable +68.51% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Hester Biosciences for 2025 predicts an additional rise of 48.32% to 53.1% by the end of 2025 with three potential targets T1: 3643.91, T2: 3691.19, T3: 3761.32. Stop Loss at SL1: 2165.25, SL2: 2135.25, SL3: 2113.65.
Hester Biosciences has a All-Time high of ₹3379.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹1292.84, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Hester Biosciences, we have created a specific page for that check here: Hester Biosciences Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Hester Biosciences Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Hester Biosciences share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 16.32% over the next 15 years.
For complete year by year Hester Biosciences long term share price target from 2024, 2025 to 2039 check the below table.
Hester Biosciences Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Hester Biosciences Target | YoY Change % |
|---|---|---|
| 2024 | ₹2,456.69 | [Current Price] |
| 2024 | ₹2,698.9 | 9.85% |
| 2025 | ₹4,174.96 | 54.69% |
| 2026 | ₹6,783.61 | 62.48% |
| 2027 | ₹8,633.61 | 27.27% |
| 2028 | ₹8,951.99 | 3.68% |
| 2029 | ₹9,630.16 | 7.57% |
| 2030 | ₹11,258.59 | 16.9% |
| 2031 | ₹15,377.18 | 36.58% |
| 2032 | ₹17,359.88 | 12.89% |
| 2033 | ₹16,478.59 | -5.08% |
| 2034 | ₹16,561.41 | 0.5% |
| 2035 | ₹18,342.22 | 10.75% |
| 2036 | ₹23,970.76 | 30.68% |
| 2037 | ₹26,086.15 | 8.82% |
| 2038 | ₹24,005.18 | -7.98% |
| 2039 | ₹22,415.41 | -6.63% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Hester Biosciences Past Performance
- In 1995, Hester Biosciences opening price was ₹13.78
- As of Thu 14 Nov 2024 the price stands at ₹2,456.69.
- This represents a Compound Annual Growth Rate (CAGR) of 18.86%.
- In 29 years, an investment of 10,000 would have become ₹17.82 Lakh.
As we wrap up, we hope you like our study on Hester Biosciences share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Hester Biosciences Share Price History
- Hester Biosciences Price Target Tomorrow
- Hester Biosciences Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
